| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 39.886 | 72.800 | 70.771 | 81.624 | 115.656 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 39.886 | 72.801 | 70.771 | 81.624 | 115.768 |
| Total Expenses - EUR | - | 0 | 0 | 0 | 0 | 19.733 | 39.923 | 44.894 | 58.624 | 88.431 |
| Gross Profit/Loss - EUR | - | 0 | 0 | 0 | 0 | 20.153 | 32.878 | 25.878 | 23.000 | 27.337 |
| Net Profit/Loss - EUR | - | 0 | 0 | 0 | 0 | 19.770 | 32.150 | 25.170 | 22.184 | 23.863 |
| Employees | - | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Morar Gabriela Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 892 | 2.919 | 2.009 |
| Current Assets | - | 45 | 44 | 43 | 42 | 23.924 | 46.375 | 39.037 | 52.315 | 47.603 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 8.534 | 9.372 | 6.142 | 45.190 | 42.450 |
| Cash | - | 45 | 44 | 43 | 42 | 15.390 | 37.003 | 32.895 | 7.125 | 5.153 |
| Shareholders Funds | - | 45 | 44 | 43 | 42 | 19.811 | 43.460 | 25.210 | 22.224 | 23.904 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 0 | 0 | 0 | 4.113 | 2.916 | 14.718 | 33.010 | 25.709 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Morar Gabriela Medica Srl